Rock Creek Pharmaceuticals
RCPI
RCPI was delisted on the 4th of November, 2015.
36 hedge funds and large institutions have $1.73M invested in Rock Creek Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 29 closing their positions.
245% more capital inflows, than outflows
Capital inflows: $1.24M | Capital outflows: $358K
91% more call options, than puts
Call options by funds: $193K | Put options by funds: $101K
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
39% less funds holding
Funds holding: 59 → 36 (-23)
79% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tenor Capital Management
New York
|
+$443K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$293K |
| 3 |
Virtu KCG Holdings
New York
|
+$173K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$118K |
| 5 |
BlackRock Institutional Trust
San Francisco,
California
|
+$89.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$80K |
| 2 |
GCM
Goldman Capital Management
New York
|
-$66.1K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$26K |
| 4 |
KCM
Kempner Capital Management
Galveston,
Texas
|
-$24K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$21.4K |
RCPI Hedge Fund Activity: Q2 2015 in Review
36 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Rock Creek Pharmaceuticals (RCPI) for Q2 2015, worth a combined $1.73M — down 11% from $1.95M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of RCPI and 6 opened new positions — a net loss of 23 holders — while 7 trimmed existing stakes and 11 added.
The largest buyer was Tenor Capital Management, opening a new position worth an estimated $443K. The largest seller was Geode Capital Management, exiting entirely with an estimated $80K sold.
- 36 institutional investors held Rock Creek Pharmaceuticals (RCPI) as of Q2 2015, down from 59 in Q1 2015.
- Funds reported $1.73M of Rock Creek Pharmaceuticals stock for Q2 2015, down 11% quarter-over-quarter.
- 6 funds opened new Rock Creek Pharmaceuticals positions in Q2 2015 and 29 closed out, a net change of -23 holders.
- The largest Rock Creek Pharmaceuticals buyer in Q2 2015 was Tenor Capital Management, an estimated $443K added.
- The largest Rock Creek Pharmaceuticals seller in Q2 2015 was Geode Capital Management, an estimated $80K sold.
Based on aggregated 13F filings for Q2 2015.